Defining, Classifying and Subtyping Lymphoid Neoplasms in the Era of Genomics and Precision Medicine – Balancing the Multitude of Drivers that Shape the Biology

Kikkeri Naresh, MBBS, DCP, MD, FRCPath
Professor, Clinical Research Division, Fred Hutch
Section Head, Pathology, Clinical Research Division, Fred Hutch
Department of Laboratory Medicine & Pathology
University of Washington

Objectives:

1. Understand the characteristics that contribute to the definition and classification of lymphomas.
2. Understand the difference between lymphoma types and subtypes, and the impact of subtyping. Also understand the difference between lymphoma subtyping and disease stratification.
3. Appreciate the contribution of genomics to lymphoma classification and subtyping – also understand the current limitations.

Speaker disclosures: Dr. Kikkeri Naresh has NOT had any financial relationships with any ineligible entities within the past 24 months.

Why Attend? 

Cancer definition and classification is the cornerstone of diagnosis, management, and research. Lymphomas are a collection of large numbers of cancers of the lymphoid cells. Defining, classifying, and subtyping lymphomas is complex and weighs a multitude of factors. The era of genomics has provided enormous opportunities to refine these and make the system relevant for precision and personalized medicine. It has however, also thrown many challenges. The seminar will explore these aspects from the perspective of a pathologist.

Grant Acknowledgment:  None

Planning Committee Disclosure:

The following members have not had any financial relationships with any ineligible entities in the past 24 months: Drs. Rebecca Alvarez, Eleanor Chen, Lisa Koch, Jose Mantilla, Elizabeth Parker, Maria Tretiakova, Larry True, James Malleis, and Trent Irwin.

The following members disclose financial relations with ineligible entities within the past 24 months: Dr Shreeram Akilesh discloses a financial relationship (speaker honorarium) with GoldfinchBio, Inc.;  Dr. Haodong Xu discloses a financial relationship with PathomIQ (consultant).

All relevant financial relationships listed have been mitigated.

You must sign-in on the following form to receive CME credit. Sign-in online: https://forms.gle/W2oE8d3MYbnyTDe58

The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 

The University of Washington School of Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit)